Pharmacokinetics in children

Not relevant for vaccines

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects in children

Reactions at the vaccination site: tenderness (19.9%) and pain (19.3%)

Most common side effects in children aged 12-18 years: headache (51.0%), myalgia (26.9%), fever (24.1%), fatigue (22.3%), nausea (15.9%), and arthralgia (12.9%).

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Reference

1. Valneva Austria GmbH, SmPC Ixchiq (EU/1/24/1828/001) 12-5-2025

Changes

Therapeutic Drug Monitoring

Overdose